For citations:

Smorodin Е.Р. RELEVANCE OF FURTHER CLINICAL TRIALS OF THE USE OF MELATONIN IN ADJUVANT CANCER THERAPY. Russian Journal of Biotherapy. 2021;20(1):24-32. (In Russ.) https://doi.org/10.17650/1726-9784-2021-20-1-24-32